Jazz Pharmaceuticals Announces Orphan Drug Exclusivity for Xywav™ (calcium, magnesium, potassium, and sodium oxybates) Oral SolutionPRNewsWire • 06/25/21
Jazz Pharmaceuticals Updates 2021 Financial Guidance to Include Recently Acquired GW Pharmaceuticals plcPRNewsWire • 06/17/21
Jazz Pharmaceuticals and Leading Cancer Organizations Collaborate to Launch First and Only Digital Hub Focused Exclusively on Emotional, Social and Physical Health Needs of Small Cell Lung Cancer CommunityPRNewsWire • 06/14/21
Monteverde & Associates PC Filed A Class Action Lawsuit On Behalf Of Shareholders Of GW Pharmaceuticals, PLC In The Southern District Of CaliforniaPRNewsWire • 06/04/21
Jazz Pharmaceuticals to Participate in Jefferies Virtual Healthcare Conference on June 2, 2021PRNewsWire • 05/26/21
Jazz to Present New Data at ASCO and EHA 2021 Meetings Showcasing Clinical Advances Across Hematology and Oncology PortfolioPRNewsWire • 05/20/21
Jazz Pharmaceuticals Closes On Acquisition Of GW Pharma, Adds CBD Drug Epidiolex To PortfolioBenzinga • 05/06/21
Strength Seen in Jazz (JAZZ): Can Its 6.6% Jump Turn into More Strength?Zacks Investment Research • 05/06/21